
Ozempic-style drugs could slash complication risks after heart attacks, research suggests
Fox News
GLP-1 drugs, including semaglutide, may prevent deadly heart complications by opening blocked blood vessels after heart attacks, new research finds.
Khloe Quill is a lifestyle production assistant with Fox News Digital. She and the lifestyle team cover a range of story topics including food and drink, travel, and health.
This discovery appears to explain how GLP-1 drugs — which mimic glucagon-like peptide-1, a hormone that helps regulate blood sugar and appetite — protect heart tissue from a condition known as "no-reflow."
"In nearly half of all heart attack patients, tiny blood vessels within the heart muscle remain narrowed, even after the main artery is cleared during emergency medical treatment," Dr. Svetlana Mastitskaya, the study’s lead author and a senior lecturer at Bristol Medical School, said in a press release.













